![]() |
Volumn 341, Issue 6152, 2013, Pages 1345-1346
|
Mitochondrial replacement, evolution, and the clinic
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MITOCHONDRIAL DNA;
DISEASE SEVERITY;
DISEASE TREATMENT;
HEALTH RISK;
MITOCHONDRIAL DNA;
MITOCHONDRION;
RESEARCH AND DEVELOPMENT;
RESEARCH WORK;
CYTOPLASM;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
EVOLUTION;
FERTILIZATION IN VITRO;
GENE MUTATION;
GENETIC DIFFERENCE;
HAPLOTYPE;
HEREDITY;
HOSPITAL;
HUMAN;
HUMAN EMBRYO;
INHERITANCE;
MACACA;
MITOCHONDRIAL REPLACEMENT;
MITOCHONDRION;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
OOCYTE;
PRIORITY JOURNAL;
PROGENY;
SHORT SURVEY;
SUBSTITUTION THERAPY;
TREATMENT OUTCOME;
UNITED KINGDOM;
ANIMAL;
ARTICLE;
FEMALE;
GENE THERAPY;
GENETICS;
GERM CELL;
MALE;
METHODOLOGY;
MOUSE;
MUTATION;
RISK;
ULTRASTRUCTURE;
UNITED KINGDOM;
ANIMALS;
DNA, MITOCHONDRIAL;
FEMALE;
FERTILIZATION IN VITRO;
GENETIC THERAPY;
GERM CELLS;
HUMANS;
MACACA;
MALE;
MICE;
MITOCHONDRIA;
MITOCHONDRIAL DISEASES;
MUTATION;
OOCYTES;
RISK;
|
EID: 84884643465
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1237146 Document Type: Short Survey |
Times cited : (137)
|
References (15)
|